Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BRID
BRID logo

BRID Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Bridgford Foods Corp (BRID) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
7.610
1 Day change
-1.42%
52 Week Range
8.740
Analysis Updated At
2026/05/22
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

BRID is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has no strong proprietary buy signal, technicals are neutral, there is no recent news catalyst, and the latest move shows weakness with a 5.38% drop despite a closed market. The only supportive point is strong recent insider buying, but that is not enough to justify an immediate buy given the lack of momentum and absence of clear fundamental confirmation.

Technical Analysis

The technical picture is mixed to neutral. MACD histogram is slightly positive at 0.0215 and contracting, which suggests weak bullish momentum but not a strong trend. RSI_6 at 46.338 is neutral, showing neither oversold nor overbought conditions. Moving averages are converging, which usually indicates indecision rather than a confirmed uptrend. Price is trading around 7.73, below the pivot at 7.831 and near support at 7.56, with resistance at 8.102 and 8.27. Overall, the chart does not show a convincing upward trend, and the recent -5.38% move adds near-term weakness.

Positive Catalysts

  • ["Insiders are buying, with insider buying up 336.66% over the last month.", "MACD histogram is slightly positive, indicating limited improving momentum.", "Price is near support levels, which may attract buyers if momentum improves."]

Neutral/Negative Catalysts

  • ["No news in the recent week, so there is no current event-driven catalyst.", "Hedge funds are neutral with no significant trading trends over the last quarter.", "The stock fell 5.38%, signaling recent weakness.", "No AI Stock Picker signal today.", "No SwingMax signal recently.", "No recent congress trading data available.", "Similar candlestick pattern analysis shows only modest expected gains and meaningful downside probability in the next day."]

Financial Performance

No quarterly financial snapshot was available because the provided financial data returned an error, so there is no reliable latest-quarter seasonal revenue or earnings trend to assess.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so Wall Street sentiment cannot be confirmed. Based on the available data, pros are limited to insider buying and a slightly improving MACD, while cons include weak recent price action, neutral hedge fund activity, no news catalyst, and no proprietary buy signal.

Wall Street analysts forecast BRID stock price to rise
Analyst Rating
0
Wall Street analysts forecast BRID stock price to rise
Buy
Hold
Sell
0
Current: 7.610
sliders
Low
0
Averages
0
High
0
0
Current: 7.610
sliders
Low
0
Averages
0
High
0
Wells Fargo
Tiago Fauth
Overweight
maintain
$84 -> $88
AI Analysis
2026-01-20
Reason
Wells Fargo
Tiago Fauth
Price Target
$84 -> $88
AI Analysis
2026-01-20
maintain
Overweight
Reason
Wells Fargo analyst Tiago Fauth raised the firm's price target on BridgeBio to $88 from $84 and keeps an Overweight rating on the shares. The firm notes Attruby revenues posted a solid Q4 beat, and Wells is raising its FY26 estimates by up 10%. The firm conservatively models some seasonality for Q1 but consistent quarter-over-quarter growth Q2-Q4 in 2026.
Truist
Buy
maintain
$80 -> $86
2026-01-08
Reason
Truist
Price Target
$80 -> $86
2026-01-08
maintain
Buy
Reason
Truist raised the firm's price target on BridgeBio to $86 from $80 and keeps a Buy rating on the shares. The firm updated its model, but tells investors in a research note that the fundamental views remain intact from 2025.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BRID
Unlock Now

People Also Watch